Analysis of information sources in references of the Wikipedia article "Rối loạn tăng động giảm chú ý" in Vietnamese language version.
Consensus estimates from more than 30 twin studies indicate that the heritability of ADHD is 70–80% throughout the lifespan and that environmental risks are those not shared by siblings. Nghiên cứu trên các cặp song sinh cũng cho thấy Twin studies also suggest that diagnosed ADHD represents the extreme tail of one or more heritable quantitative traits.
Các báo cáo cho thấy tỷ lệ người trưởng thành chịu ảnh hưởng của ADHD là 2,5%–5%,5–8 so với tỷ lệ ở trẻ em là 5%–7%.9,10 ... Tuy nhiên, hiện nay dưới 20% số người trưởng thành mắc ADHD được các bác sĩ tâm lý chẩn đoán và/hoặc điều trị.7,15,16
Results suggest there is moderate-to-high-level evidence that combined pharmacological and behavioral interventions, and pharmacological interventions alone can be effective in managing the core ADHD symptoms and academic performance at 14 months. However, the effect size may decrease beyond this period. ... Only one paper examining outcomes beyond 36 months met the review criteria. ... There is high level evidence suggesting that pharmacological treatment can have a major beneficial effect on the core symptoms of ADHD (hyperactivity, inattention, and impulsivity) in approximately 80% of cases compared with placebo controls, in the short term.22
Consensus estimates from more than 30 twin studies indicate that the heritability of ADHD is 70–80% throughout the lifespan and that environmental risks are those not shared by siblings. Nghiên cứu trên các cặp song sinh cũng cho thấy Twin studies also suggest that diagnosed ADHD represents the extreme tail of one or more heritable quantitative traits.
Consensus estimates from more than 30 twin studies indicate that the heritability of ADHD is 70–80% throughout the lifespan and that environmental risks are those not shared by siblings. Nghiên cứu trên các cặp song sinh cũng cho thấy Twin studies also suggest that diagnosed ADHD represents the extreme tail of one or more heritable quantitative traits.
Các báo cáo cho thấy tỷ lệ người trưởng thành chịu ảnh hưởng của ADHD là 2,5%–5%,5–8 so với tỷ lệ ở trẻ em là 5%–7%.9,10 ... Tuy nhiên, hiện nay dưới 20% số người trưởng thành mắc ADHD được các bác sĩ tâm lý chẩn đoán và/hoặc điều trị.7,15,16
likelihood that the adult with ADHD has developed coping mechanisms to compensate for his or her impairment
Results suggest there is moderate-to-high-level evidence that combined pharmacological and behavioral interventions, and pharmacological interventions alone can be effective in managing the core ADHD symptoms and academic performance at 14 months. However, the effect size may decrease beyond this period. ... Only one paper examining outcomes beyond 36 months met the review criteria. ... There is high level evidence suggesting that pharmacological treatment can have a major beneficial effect on the core symptoms of ADHD (hyperactivity, inattention, and impulsivity) in approximately 80% of cases compared with placebo controls, in the short term.22
Consensus estimates from more than 30 twin studies indicate that the heritability of ADHD is 70–80% throughout the lifespan and that environmental risks are those not shared by siblings. Nghiên cứu trên các cặp song sinh cũng cho thấy Twin studies also suggest that diagnosed ADHD represents the extreme tail of one or more heritable quantitative traits.
Các báo cáo cho thấy tỷ lệ người trưởng thành chịu ảnh hưởng của ADHD là 2,5%–5%,5–8 so với tỷ lệ ở trẻ em là 5%–7%.9,10 ... Tuy nhiên, hiện nay dưới 20% số người trưởng thành mắc ADHD được các bác sĩ tâm lý chẩn đoán và/hoặc điều trị.7,15,16
likelihood that the adult with ADHD has developed coping mechanisms to compensate for his or her impairment
Results suggest there is moderate-to-high-level evidence that combined pharmacological and behavioral interventions, and pharmacological interventions alone can be effective in managing the core ADHD symptoms and academic performance at 14 months. However, the effect size may decrease beyond this period. ... Only one paper examining outcomes beyond 36 months met the review criteria. ... There is high level evidence suggesting that pharmacological treatment can have a major beneficial effect on the core symptoms of ADHD (hyperactivity, inattention, and impulsivity) in approximately 80% of cases compared with placebo controls, in the short term.22
